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Introduction:  Cervicofacial  cellulitis  (CFC)  is a severe  infection  of  the subcutaneous  cellular  tissue, and  is
one of  the  most  serious  head  and  neck  infectious  emergencies.  In  a series  of 70  cases  treated  between
2007  and  2012,  we noticed  a strong  correlation  between  use  of non-steroidal  anti-inﬂammatory  drugs
(NSAIDs)  and evolution  of  head  and  neck  infections  toward  CFC,  including  two  cases  of  necrotic  CFC
extending  to the  mediastinum,  which  were  fatal.
Material  and methods:  The  cases  included  in  the  series  comprised  patients  admitted  to  emergency  and
requiring  hospitalization  due  to the  severity  of presenting  symptoms.  There  were  70 such  cases  of  CFC
between  2007  and  2012;  cases  managed  on  an  outpatient  basis  were  excluded,  as were  cases  of  orbital
CFC,  CFC  of  sinus  origin  and mastoiditis.
Results:  Eighty  percent  of patients  took  NSAIDs,  on  self-medication  or by  prescription  (community
physician,  dentist,  pharmacist).  The  most  frequent  molecules  were  tiaprofenic  acid  and  diclofenac.  CFC
extension was  restricted  in most  cases  to  the  maxillary  and/or  ipsilateral  subhyoid  region,  with  5  cases
of  lower  cervical  extension  and 2 of  mediastinal  involvement,  which  both  proved  fatal.
Conclusion:  CFC is  a severe  infection  that can  be life-threatening,  and  represents  a  diagnostic  and  thera-
peutic  emergency.  Among  other  risk  factors,  use  of  NSAIDs  is frequently  reported;  these  should  therefore
be  used  with  caution  if at all in head  and  neck  infection,  especially  of odonto-stomatological  origin.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Cervicofacial cellulitis (CFC) is one of the most frequent head
nd neck infectious emergencies and also one of the most seri-
us. Mortality is non-negligible despite diagnostic and therapeutic
rogress.
It is an infection of the cellulo-adipose spaces of the head and
eck, mainly of oro-dental (70%) or oropharyngeal (20%) origin
1,2]. Most cases are localized acute forms without signs of severity
serous and suppurating forms), rapidly resolved by correct med-
cal and surgical management, but others may  be life-threatening
ue to rapid spread causing extensive cellulitis that may  involve
he mediastinum, or to particular aggressiveness, with extensive
ecrosis (necrotizing fasciitis).
∗ Corresponding author.
E-mail address: dr.a.bennani@gmail.com (A.A. Bennani-Baïti).
http://dx.doi.org/10.1016/j.anorl.2015.06.004
879-7296/© 2015 Elsevier Masson SAS. All rights reserved.Nosologically, the term “necrotizing fasciitis” is used in English
as a generic term for all types of cellulitis, whereas the term “cel-
lulitis” actually covers a very wide range of pathologies, from
purulence to extensive necrosis, the latter being the object of the
French term fasciite nécrosante.
Severe forms may  be due to incomplete or unsuitable treatment
(antibiotherapy not adapted to bacteriology, insufﬁcient surgical
resection of necrotic tissue) or to an underlying predisposition
impairing the organism’s defenses (diabetes, congenital or acquired
immune deﬁciency).
As well as these known risk factors, overprescription of non-
steroidal anti-inﬂammatory drugs (NSAIDs) has frequently been
reported as associated with complications in CFC, although the
causal link has not been deﬁnitively established.
In our practice in the ENT and Head and Neck Surgery Depart-
ment of the Specialties Hospital of Rabat (Morocco), we  regularly
noticed a high frequency of NSAID use by patients presenting CFC
requiring hospitalization. This clinical observation underlay the
present prospective cohort study covering a 5-year period, to deter-
mine the impact of NSAIDs on the evolution of CFC.
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associated to metronidazole 1 g/day: n = 12 patients;
• ceftriaxone 8 mg/kg/day: n = 13 patients;
• moxiﬂoxacin 400 mg/day: n = 8 patients82 A.A. Bennani-Baïti et al. / European Annals of Otorhin
. Patients and methods
A prospective study was performed between, September 2007
nd January 2012, in the ENT and H&N Surgery department of the
pecialties Hospital of Rabat (Morocco).
Patients admitted to the Emergency Department of the Rabat
pecialties Hospital for CFC and hospitalized due to the severity
f their presenting symptoms were included. The numerous cases
hat could be managed on an outpatient basis were excluded for
rganizational reasons: loss to follow-up, missing data, etc.
Data were collected on a form detailing, among other points:
probable or proven origin of infection (dental, oral, oropharyn-
geal, adenitis, etc.);
NSAID intake in the period preceding CFC onset: molecule, dose,
treatment duration and prescription modalities (self-medication,
specialist or non-specialist medical prescription);
risk factors: diabetes, long-course corticotherapy, other immune
deﬁciency factors;
pre- and post-admission assessment: blood tests, bacteriol-
ogy, contrast-enhanced CT, and management after admission
(surgery, intensive care).
. Results
Between 2007 and 2012, 70 patients were recruited: 43 male, 27
emale (sex ratio 1.59); age ranging from 8 to 65 years old (median
ge 33 years).
Fifteen ﬁles lacked data (pre-assessment use of undetermined
elf- or prescription-medication) and were therefore excluded.
.1. History
Nineteen patients had type-2 diabetes (27.41%), all with poor
lycemic control at admission (glycemia > 2 g/dL). In 5 patients, the
FC revealed the diabetes.
There were no cases of long-course corticotherapy or of congen-
tal or acquired immune deﬁciency.
.2. Functional symptomatology
Dental pain or treatment in the days preceding symptom onset
as reported in 53 patients (75.7%). These patients showed lim-
tations in mouth opening of varying severity, this being part of
he reasons for admission. All had pain, exacerbated on palpation,
t the CFC site; there was little fever, probably due to NSAIDs or
aracetamol.
.3. Origin of CFC
CFC origin was dental in 61 patients (87.14%), suggested by the
atient at admission or on interview in terms of dental pain or
reatment (53 patients).
This was conﬁrmed clinically by ﬁndings of tooth decay or
esidual root, and/or radiologically by systematic pantomogram
evealing dental origin in the patients without dental presenting
ymptoms.
CFC origin was presumed to be tonsillar in 2 cases. Adenitis was
mplicated in 1 case. Origin was undetermined in 6 cases.
.4. Associated signsForty-seven patients showed limitation of mouth opening
67.14% of the overall series and 77.05% of CFCs of dental origin);
1 presented an edema of the ﬂoor of the mouth and 5 had slightgology, Head and Neck diseases 132 (2015) 181–184
dysphagia. Impact on general health status was moderate in all
cases.
3.5. CFC site and extension
CFC was restricted to the maxillary and superolateral cervical
regions in 60 patients (85%).
Tumefaction was hard, pre-collected without skin inﬂammation
in 22 cases, and ﬂuctuating, with skin inﬂammation, in 48.
Extension was toward the temporal region in 3 cases, and the
inferolateral cervical region in 5. There was  mediastinal involve-
ment in 2 patients, who had taken NSAIDs, with fatal outcome
despite intensive care (Fig. 1).
3.6. Assessment
Standard biological assessment systematically comprised com-
plete blood count and electrolyte analysis, screening for glycemic
variability and associated hydroelectrolytic disorder.
A sample was  taken for bacteriology whenever a purulent gath-
ering was  located, including in patients taking antibiotics before
admission. In 10 cases (10.83%), multi-bacterial ﬂora was  found,
comprising cocci and Gram-negative bacilli.
Sixty-one patients underwent pantomography, and contrast
enhanced CT was performed systematically to screen for purulence
and assess deep extension.
3.7. Pre-admission treatments
NSAIDs were being taken by 56 patients (80%).
The two  most frequently prescribed molecules were tiaprofenic
acid and diclofenac, in association in some cases.
In addition to NSAIDs, all patients had been taking one or more
antibiotics before admission to emergency, prescribed by their
community physician (n = 22), dentist (n = 19) or specialist (n = 2)
or in self-medication (n = 27). The most frequent molecules were
associated metronidazole-spiramycin, metronidazole, amoxicillin-
clavulanic acid, ciproﬂoxacin, and oﬂoxacin.
3.8. Treatments in hospital
All purulent gatherings were evacuated by puncture if small and
by drainage if larger.
In 3 cases, a Sebilleau incision was made, with careful necro-
sectomy and lavage with oxygenated water and povidone-iodine.
Extensive drainage on a mediastinal approach via thoracotomy was
performed in 2 cases.
Parenteral antibiotherapy was  administered until clinical
improvement in symptoms was achieved and oral antibiotics could
be substituted. Antibiotherapy associated:
• amoxicillin + clavulanic acid 100 mg/kg/day in 3 fractions, IM gen-
tamicin 3 mg/kg/day: n = 37 patients;
• amoxicillin + clavulanic acid and gentamicin at the above doses,Mean hospital stay was 5 days (range, 3–12 days, except for 2
patients requiring ICU admission for mediastinal extension of CFC;
both died despite intensive care and surgical debridement extend-
ing to the mediastinum).
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vig. 1. a: cervical cellulitis extending to thorax, with skin necrosis; b: cellulitis exte
he  anterior mediastinum.
. Discussion
Although NSAIDs cannot be incriminated in CFC with absolute
ertainty, several series, including the present, tend to implicate
hem, if not as a direct causal factor then at least as promoting
r aggravating CFC. Mathieu et al. [2], in a series of 45 patients
dmitted with CFC, found NSAID use in 44% of cases. Merle et al. [3]
ighlighted NSAIDs as promoting CFC, reporting a 76.46% NSAID
ate, similar to the present ﬁndings but in a smaller series of
nly 17 patients presenting with odontogenic CFC; 8 presented
ediastinitis, 4 of whom had taken NSAIDs, and 7 of whom
ied.
In a larger series of 94 CFC patients admitted to intensive care
etween 1995 and 2005, Shaikh et al. reported NSAID use in 80%
f patients [4]. An association between cellulitis complicated by
dontogenic mediastinitis and NSAID use was reported in several
ther studies [3–9].
Cellulitis other than cervicofacial has also been reported, with
SAIDs implicated in evolution toward fatal necrotizing fasciitis
10].
This correlation may  be explained by the action mechanism of
SAIDs against inﬂammation, which is after all basically a non-
peciﬁc defense mechanism against microbial invasion.
NSAIDs inhibit the degradation of cellular arachidonic acid by
he cyclooxygenase pathway, preventing production of thrombox-
ne A2 and prostaglandin, which play an important role in cellular
hemotaxis. NSAIDs thus oppose polynucleate cell and macrophage
igration and phagocytosis.
They also reduce the early signs of inﬂammation, thus delaying
onsultation [11,12].
The harmful impact of NSAIDs in infection was borne out
y experimental studies, including that by Solberg et al. on
henylbutazone, demonstrating impaired granulocyte activation,
hagocytosis and intracellular destruction of streptococci and
taphylococci in vitro [13].
However, while the clinical and in vitro role of NSAIDs in aggra-
ating infection has been often reported [11], some animal studies to supraclavicular fossa; c: mediastinal approach via thoracotomy, showing pus in
found no signiﬁcant difference between experimental groups with
CFC taking diclofenac versus placebo [11,12].
However, these studies had very small samples (some 20 indi-
viduals per arm), and the origin of infection was subcutaneous
injection, as opposed to odontogenic or oropharyngeal in the great
majority of human series. The animal models fail to fully repro-
duce the anatomic and bacteriological conditions found as CFC risk
factors in humans.
Even so, other animal studies conﬁrmed the role of NSAIDs in
aggravating cellular tissue infection [14].
In the USA, the Center for Disease Control and Prevention (CDC)
advised against prescribing NSAIDs in non-controlled infection or
at least performing systematic assessment within 48–72 hours to
track evolution [1].
CFC affects all age groups, with a mean age at onset of
about 40 years [15,16]. In the present series, mean age was 33
years – probably due to the younger age pyramid found in Morocco.
Pediatric forms are much less common, as in the present series
with only seven 8–15 year-old. This may  be due to the absence
of certain CFC risk factors such as smoking and alcohol consump-
tion. There have, however, been several reports of extensive CFC in
children, including mediastinal extension [17]. Mediastinal exten-
sion may  be primary in certain particularly aggressive forms (with
weakened diathesis or use of NSAIDs) or following late or deﬁcient
management. It is facilitated by conjunction of cervical aponeu-
roses into routes of infection. Infection from the last mandibular
molars may  directly contaminate the cervical and para-tonsillar
regions (also known as anterior subparotid or pterygopharyn-
geal), which represent a strategic crossroads for extension to other
cervical spaces and the mediastinum via the vascular route and
detachable Reinke’s space.
CFC affects males more than females. Umeda et al. [18], in a
review of 125 cases, reported a sex ratio of 3:1; in the present series
there was  likewise male predominance.
In the present series, the main CFC risk factor, other than
NSAIDs, was  diabetes (27.41%). Most of these patients had
poor glycemic control. Diabetes is a known factor of immune
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ysfunction [18–21], with elevated risk of non-speciﬁc infection
19]. Apart from infection of the extremities, cellulitis is one of the
ost common infections in diabetes [21], especially with infection
ites such as tooth decay and dental apical granuloma.
Other immune system risk factors include HIV infection, liver
irrhosis, kidney failure and heart failure [18], although these were
ot found in the present series.
CFC propagates by contiguity from a dental (70%) or pharyngeal
20%) entry point [2,22–24]. Other possible etiologies are cutaneous
noculation or periadenitis.
In the present series, origin was principally dental (87.14%), a
lightly higher rate than in the literature. This may  be due to deﬁ-
ient oral and dental hygiene or to low socioeconomic status.
Extensive CFC is, as stressed above, an infection by contiguity,
raveling along the fascias and communications of the face and neck
1]. Necrosis ﬁrst involves less well-vascularized and oxygenated
issue such as fascia, extending to better vascularized tissue such
s subcutaneous fat and muscle [1].
Infection is usually multimicrobial, usually both aerobic and
naerobic [1,24,25], with synergic action: aerobic bacteria exhaust
he oxidative defenses of immune cells (macrophages, granulocytes
nd monocytes), favoring the development of anaerobic bacteria
1].
The most frequent pathogen is Streptococcus pyogenes, although
ther strains have also been isolated: Enterobacter, Fusobacterium,
acteroides,  and Staphylococci [24]. One study found as many as 11
ifferent strains in a single patient [25].
In the present series, 10 samples indicated multibacterial coccus
nd Gram-negative ﬂora. The other, negative, ﬁndings may  have
een due to antibiotics taken before admission.
The multimicrobial nature of CFC highlights the interest of early
road-spectrum probabilistic antibiotherapy awaiting bacteriology
nd the antibiogram [24,26]. However, medical treatment alone
annot be curative as the purulent gatherings contained within
ecrotic tissue are disconnected from the vascular system, preven-
ing diffusion of antibiotics, even if parenteral. In the present series,
rimary broad-spectrum probabilistic antibiotherapy was imple-
ented and followed, whenever necessary, by drainage and more
r less complete surgical debridement.
Mortality in the literature ranges between 19 and 40% [24], illus-
rating the extreme seriousness of this infection; in the present
eries, the rate of cure was 98.59%. Two deaths followed extensive
ediastinal involvement.
. Conclusion
Cervicofacial cellulitis is a serious infectious emergency requir-
ng rapid adapted treatment.
Non-steroidal anti-inﬂammatory drugs impair immune system
unctioning and mask clinical presentation, delaying diagnosis and
hus constituting a real risk factor for aggravation.
We  would like to stress the fact that, although the present
eries showed a strong correlation between NSAIDs and CFC, this
oes not prove causality (because of possible recruitment bias
nd the routine prescription of NSAIDs), but at least it should
e seen as an aggravating factor, invoking the precautionary
rinciple.
Thus many health authorities, including the American CDC, rec-
mmend selective replacement of NSAIDs by the usual analgesics
nd antipyretics.The present study is a call for all those involved in the ENT sphere
ENT specialists, maxillofacial surgeons and dentists) and commu-
ity physicians to rationalize their NSAID prescriptions, and for
trict respect of the indications for this class of drug.
[gology, Head and Neck diseases 132 (2015) 181–184
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